Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.53
Delayed Data
As of Aug 24
 +0.17 / +7.20%
Today’s Change
1.69
Today|||52-Week Range
6.69
-1.94%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.36
Today’s open2.34
Day’s range2.34 - 2.74
Volume809,336
Average volume (3 months)167,064
Market cap$56.6M
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)+6.70%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...-0.02-1.74%
RNNRexahn Pharmaceutica...-0.01-3.25%
AVIRAviragen Therapeutic...-0.02-1.41%
NVETNexvet Biopharma plc-0.34-6.77%
Data as of 08/24/2016

Financials

Next reporting dateNovember 11, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs